References
- Kaplan EL, Cornaglia G. Persistent macrolide resistance among group A streptococci: the lack of accomplishment after 4 decades. Clin Infect Dis 2005; 41: 609–611.
- Cornaglia G. Macrolide resistance and Streptococcus pyogenes: molecular basis, epidemiology and clinical signifi-cance. Rev Med Microbiol 1999; 10: 1–14.
- Cornaglia G, Bryskier A. Macrolides resistance of Streptococcus pyogenes. In J.C. Pechère and E.L. Kaplan (eds.), Optimal management of streptococcal pharyngitis: epi-demiology, diagnosis, treatment and public health considera-tions. Karger AG, Basel, 2003: 150-165.
- Cornaglia G, Ligozzi M, Mazzariol A, et al. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. Emerg Inf Dis 1996; 2: 339–342.
- Marchese A, Tonoli E, Debbia EA, Schito GC. Macrolide resistance mechanisms and expression of pheno-types among Streptococcus pneumoniae circulating in Italy. J Antimicrob Chemother 1999; 44: 461–464.
- Cornaglia G, Lo Cascio G, Masala L, et al. Macrolide resistance among Streptococcus pneumoniae isolates in Italy. In: S.H. Zinner, L.S. Young, F. Acar and C. Ortiz-Neu (eds.), New Considerations for Macrolides, Azalides, Streptogramins, and Ketolides. Marcel Dekker, Inc., New York, 1999: 250-254.
- Marchese A, Gualco L, Cochetti I, et al. Antibiotic sus-ceptibility and serotype distribution in Streptococcus pneumo-niae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). Int J Antimicrob Agents 2005; 26: 138–145.
- Reinert RR, Reinert S, van der Linden M, et al. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother 2005; 49: 2903–2913.
- Kataja, J, Huovinen P, Skurnik M, et al. Erythromycin resistance in Group A streptococci in Finland. Antimicrob Agents Chemother 1999; 43: 48–52.
- Maruyama S, Yoshioka H, Fujita K, et al. Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. Am J Dis Child 1979; 133: 1143–1145.
- Bassetti M, Mantero E, Gatti G, et al. Streptococcus pyogenes erythromycin resistance in Italy. Emerg Infect Dis 1999; 5: 302–303.
- Perez-Trallero E, Marimem JM, Montes M, et al. Clonal differences among erythromycin-resistant Streptococcus pyo-genes in Spain. Emerg Infect Dis 1999; 5: 235–240.
- Bemel-Melchior P, Juvin ME, Tassin S, et al. In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors. Antimicrob Agents Chemother 2000; 44: 2999–3002.
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement. CLSI document M100-516. 2005. Clinical and Laboratory Standards Institute. Villanova, Pa.
- Seppala H, Nissinen A, Yu Q, Huovinen P. Three dif-ferent phenotypes of erythromycin-resistant S. pyogenes in Finland. J Antimicrob Chemother 1993; 32: 885–891.
- Daly MM, Doktor S, Flamm R, Shortridge D. Characterization and prevalence of MefA, MefE, and the asso-ciated msr(D) gene in Streptococcus pneumoniae clinical iso-lates. J Clin Microbiol 2004; 42: 3570–3574.
- Marchese A, Ardito F, Fadda G, et al. PROTEKT ITALY 2004: analysis of the results obtained from bacterial pathogens causing respiratory infections in paediatric patients. GIMMOC 2006; 10: 67–101.
- Al-Lahham A, Appelbaum PC, van der Linden M, Reinert RR. Telithromycin-nonsusceptible clinical isolates of Streptococcus pneumoniae from Europe. Antimicrob Agents Chemother. 2006; 50: 3897–3900.
- Cantem R, Mazzariol A, Morosini M-I, et al. Telithromycin activity is reduced by efflux in Streptococcus pyogenes. J Antimicrob Chemother 2005; 55: 489–495.
- Benvenuti C, Koncan R, Bahar G, et al. Telithromycin activity is reduced by efflux in Streptococcus pneumoniae. Abstracts of the 16th European Congress of Clinical Microbiology and Infectious Diseases. Nice, France, April 1-4, 2006. Abstract P1591.